Abstract:This study compared the surgical outcomes of the 120-W Thulium laser (Vela™ XL) enucleation of the prostate and bipolar transurethral resection of the prostate (TURP) in terms of efficacy, safety, and improvements of quality of life (QoL) in patients with benign prostate hyperplasia (BPH). Records were obtained from January 2014 to September 2018 for selected patients with symptomatic BPH who underwent 120-W Thulium laser (Vela™XL) prostate enucleation and bipolar TURP in our institution. All the patients selected met the surgical criteria for TURP and had received medical treatment for at least 3 months. Patients were excluded if their ECOG performance status was >1, if they had active malignant disease, of if they had a history of prostate surgery or reconstruction surgery of the urinary system. Patients decided which treatment option would be performed. Both the procedures were conducted by a single surgeon. Clinical outcomes such as changes in the International Prostate Symptom Score (IPSS) score, urodynamic parameters, drug consumption, pain scores, and QoL were evaluated. The rate of urinary tract infection, recatheterization, additional analgesic requirement, return to the emergency department for treatment, and other surgical complications was analyzed and compared between the two cohorts. A total of 276 patients met the inclusion criteria. Among them, 141 patients received bipolar TURP, where as 135 decided to receive laser vaporesection. No significant difference was observed in age, PSA level, prostate volume, and comorbidities between the two cohorts. Pre-operative (pre-op) urodynamic parameters were also identical, except that the laser surgery group had a higher rate of admission with a urinary catheter (24.4% vs. 14.2%, p=0.044). The operating time was longer in the laser surgery group (79.3 minutes vs. 62.4 minutes, p<0.001). However, enucleation using the Thulium laser was superior to bipolar TURP in terms of post-operative (post-op) pain status, including the numeric rating scale of pain, rate of additional narcotic use, and oral analgesic requirement. Compared with bipolar TURP, laser enucleation achieved a higher improvement in the QoL score at post-op follow-up at 2 weeks and 3 months. Nevertheless, the complication rate, changes in IPSS score, Qmax, and post-op medication-free survival were statistically identical in the two cohorts. Our data revealed that compared with bipolar TURP, 120-W Thulium laser (Vela™ XL) enucleation of the prostate achieved lower post-op pain and higher improvement in the short-term QoL of patients after surgery.

Short-term Postoperative Recovery for Patients after Thulium Laser Vapoenucleation of Prostate: Evaluation of the Impact of Lower Urinary Tract Symptoms on Quality of Life

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

[Effect of transurethral thuliumlaser vapoenucleation of the prostate with low-power conventional pulse mode on sexual function in patients with benign prostatic hyperplasia].

Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia.

Impact on sexual function of 2-micron thulium laser resection of the prostate-tangerine technique

AB060. Long-term Outcome Following Thulium Vaporesection of the Prostate

Impact of 120-W 2-Μm Continuous Wave Laser Vapoenucleation of the Prostate on Sexual Function.

Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (Vela™ XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male

Efficacy and Safety of Ultrasonography Guided Transperineal Percutaneous Laser Ablation for Treating Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Trial Compared with Transurethral Resection of the Prostate

Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis

Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.

[Comparison of Efficacy and Safety of Transurethral Thulium Laser Vapoenucleation of Prostate and Transurethral Thulium Laser Enucleation of Prostate in the Treatment of Benign Prostatic Hyperplasia].

Thulium Laser Versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial

Effect of dual-band semiconductor laser transurethral resection of prostate on efficacy, stress response and quality of life in patients with benign prostatic hyperplasia

Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis

Long-term Results of Thulium Laser Resection of the Prostate: a Prospective Study at Multiple Centers

Long-term results of multimodal treatment of the prostate using the Thulium Laser

[Long-Term Clinical Study of Thulium Laser Resection of Prostate-Tangerine Technique in the Treatment of Begin Prostatic Hyperplasia].

Effect and Impact of Holmium Laser Versus Thulium Laser Enucleation of the Prostate on Erectile Function

A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results

Thulium laser resection of prostate and antiandrogen therapy in treatment of patients with advanced prostatic cancer accompanied by bladder outlet obstruction